On the back of record revenues, company expands offices and recruits veteran SaaS sales leader.
OrthAlign, Inc., a privately held U.S.-based medical device company, received 510(k) clearance from the United States Food and Drug Administration (FDA) to market its UniAlign™ system, the world’s first handheld, single-use navigation device for Unicompartmental Knee Arthroplasty (UKA) surgeries.
NICO Corporation, an Indianapolis-based neurosurgery medical device manufacturer, recently completed a $15 million capital raise important to the expansion of newly developed markets created by their technologies and systems approach to subcortical brain surgery.
OrthAlign, Inc., a privately held U.S.-based medical device company, announced today that it has entered into a multi-country distribution agreement with Smith & Nephew, for its award-winning Total Knee Arthroplasty (TKA) technology, KneeAlign®.
NineSigma, the leading innovation partner to companies worldwide, today announces the growth of a new Innovation Gallery sponsored by Natural Resources Canada on NineSights.
Lattice Engines celebrates biggest quarter in its history.
We enjoyed a productive year welcoming several new portfolio companies and celebrating three successful liquidity events.
OrthAlign, Inc., a privately held U.S. based medical device company developing precision technologies, announced today that it exceeded its total 2015 sales forecasts, growing by more than 50% versus 2014. OrthAlign has exceeded sales forecasts for the past three years.
OrthAlign, Inc., a privately held U.S.-based medical device company developing precision technologies, announced today the successful completion of its limited release phase of OrthAlign Plus(R) for Total Hip Arthroplasty use in the direct anterior hip approach. The product will commercially launch at this year’s AAOS meeting in Orlando, March 2, 2016.
Randomized controlled trial to help determine best course of treatment for deadliest form of stroke.